Navigation Links
Current Severe Outbreaks of Foot and Mouth Disease Predicted by Replikins' BioRadar(TM) One Year in Advance (June 2009)
Date:7/16/2010

LONDON, July 16 /PRNewswire/ -- BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.

The Foot and Mouth Disease outbreaks now rampant in Asia are moving west to the Middle East and south to Africa. The last major FMD outbreak followed the same path of spread, and cost approximately 17 billion pounds sterling when it reached the U.K. in 2001.

BioRadar(TM) also gave warning one year in advance (January 2009, ref. 2) of the re-emergence of H5N1 (bird) influenza. H5N1 is now producing outbreaks in chickens in 63 countries. In Egypt, H5N1 has appeared in 31 human cases (40% mortality). The accuracy of these predictions is supported by the fact that BioRadar(TM) predicted, one year in advance, the H1N1 pandemic of 2009.

Dr. Samuel Bogoch, chairman of BioRadar UK Ltd., reported to the Amsterdam conference that the new technology gives accurate advance notice of virus outbreaks.

Further, two Replikins synthetic vaccines have been found by others to be effective against H5N1 influenza in chickens (TransFlu(TM)) (ref. 3) and against lethal Taura Syndrome virus in shrimp. These synthetic non-biological methods produce Replikins vaccines in 7 days rather than the six to eight months required by older biological methods. Regardless of which method of vaccine production is used, even using standard biological methods, one year of additional time to produce and test vaccines is now possible.

United Kingdom's UK Trade and Investment (UKTI) announced that BioRadar UK Ltd. has "one of the first reliable systems for accurately predicting the strain of future flu outbreaks together with the severity and duration." Subscriptions to the Replikins BioRadar Global Surveillance System(TM) are being received by BioRadar UK Ltd.

Contact: John McKenney, jMckenney@replikins.com, 617-536-0220

References:

1. Bogoch S. and Bogoch ES. Replikins: the chemistry of rapid replication. Begell House, N.Y. 2005. Library of Congress.  

2. Website: http://replikins.com, Replikins Press - 35 online reports, 2006-2010.

3. Jackwood, M. et al. Efficacy of a Replikin Peptide Vaccine Against Low Pathogenicity Avian Influenza H5 Virus. doi: 2009.10.637/8892-042509; full paper in Avian Diseases 2009.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Replikins
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
2. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
3. The hot -- and cold -- interventional radiology treatments for recurrent prostate cancer
4. Penn material scientists turn light into electrical current using a golden nanoscale system
5. Waukesha Electric partners with SuperPower and UH to build fault current limiting superconducting transformer for Dept. of Energy
6. New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
7. Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline
8. Enobia Raises US$50M from Current Investors in Series C Financing
9. Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes
10. ULURU Discussions to Acquire York Pharma, plc Are Currently Terminated
11. 2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... ... August 11, 2017 , ... A staple in the community for ... will incorporate important key elements including a new digital marketing strategy and updated logo. ... them, Bill Miller has partnered with the South Texas Blood & Tissue Center for ...
(Date:8/11/2017)... (PRWEB) , ... August 11, 2017 , ... ... food production, and, in particular, more natural alternatives to synthetic ingredients,” said Matt ... of Third Wave, with the established manufacturing presence and know-how of Biorigin will ...
(Date:8/10/2017)... ... August 09, 2017 , ... Teachers from three Philadelphia ... August 14th through the 16th, the University City Science Center will kick off ... 2016, provides Philadelphia-based middle school educators an opportunity for professional development related to ...
(Date:8/10/2017)... ... ... Each year in the United States more than 300,000 people are hospitalized for ... even worse, the one-year mortality rate is high, ranging from 12 percent to 37 ... Medical Center (Sacramento) and Second Xiangya Hospital of the Central-South University (Hunan, China) might ...
Breaking Biology Technology:
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... its 2016 Annual Report on Form 10-K on Thursday April 13, ... ... the Investor Relations section of the Company,s website at http://www.nxt-id.com ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):